ACOG: Long-term low-dose vaginal estrogen poses no apparent cancer risk

SAN FRANCISCO – The use of unopposed topical vaginal estrogen is not associated with an increased risk of endometrial hyperplasia or cancer, findings from a large database review suggest.

Yearly...